Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 3771122
[patent_doc_number] => 05807734
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Monoclonal antibodies and FV specific for CD2 antigen'
[patent_app_type] => 1
[patent_app_number] => 8/456221
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13394
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807734.pdf
[firstpage_image] =>[orig_patent_app_number] => 456221
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456221 | Monoclonal antibodies and FV specific for CD2 antigen | May 30, 1995 | Issued |
08/453013 | PORCINE ANTIBODIES TO TNF-ALPHA | May 29, 1995 | Abandoned |
Array
(
[id] => 3727936
[patent_doc_number] => 05703048
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Protection against liver damage by HGF'
[patent_app_type] => 1
[patent_app_number] => 8/452485
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 18603
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/703/05703048.pdf
[firstpage_image] =>[orig_patent_app_number] => 452485
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/452485 | Protection against liver damage by HGF | May 25, 1995 | Issued |
Array
(
[id] => 3895587
[patent_doc_number] => 05750503
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-12
[patent_title] => 'Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock'
[patent_app_type] => 1
[patent_app_number] => 8/435926
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5027
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/750/05750503.pdf
[firstpage_image] =>[orig_patent_app_number] => 435926
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/435926 | Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock | May 4, 1995 | Issued |
Array
(
[id] => 3659441
[patent_doc_number] => 05648237
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Expression of functional antibody fragments'
[patent_app_type] => 1
[patent_app_number] => 8/433781
[patent_app_country] => US
[patent_app_date] => 1995-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13687
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648237.pdf
[firstpage_image] =>[orig_patent_app_number] => 433781
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/433781 | Expression of functional antibody fragments | May 2, 1995 | Issued |
Array
(
[id] => 3868145
[patent_doc_number] => 05763195
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Method and compositions for making ACSF and ACSF antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/425491
[patent_app_country] => US
[patent_app_date] => 1995-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9478
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763195.pdf
[firstpage_image] =>[orig_patent_app_number] => 425491
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/425491 | Method and compositions for making ACSF and ACSF antagonists | Apr 19, 1995 | Issued |
Array
(
[id] => 3708090
[patent_doc_number] => 05654404
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-05
[patent_title] => 'Protection against liver damage by HGF'
[patent_app_type] => 1
[patent_app_number] => 8/419654
[patent_app_country] => US
[patent_app_date] => 1995-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 18675
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/654/05654404.pdf
[firstpage_image] =>[orig_patent_app_number] => 419654
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/419654 | Protection against liver damage by HGF | Apr 9, 1995 | Issued |
Array
(
[id] => 3701618
[patent_doc_number] => 05653979
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-05
[patent_title] => 'Immunotargeting of plasminogen activators to the pulmonary endothelium'
[patent_app_type] => 1
[patent_app_number] => 8/413415
[patent_app_country] => US
[patent_app_date] => 1995-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 3538
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/653/05653979.pdf
[firstpage_image] =>[orig_patent_app_number] => 413415
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/413415 | Immunotargeting of plasminogen activators to the pulmonary endothelium | Mar 29, 1995 | Issued |
Array
(
[id] => 3654544
[patent_doc_number] => 05591432
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-07
[patent_title] => 'Antibody to the neural cell adhesion molecule and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/405598
[patent_app_country] => US
[patent_app_date] => 1995-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4146
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/591/05591432.pdf
[firstpage_image] =>[orig_patent_app_number] => 405598
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/405598 | Antibody to the neural cell adhesion molecule and methods of use | Mar 15, 1995 | Issued |
Array
(
[id] => 3693125
[patent_doc_number] => 05650284
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Enhancing the sensitivity of immunoassay procedures by use of antibodies directed to the product of a reaction between probe labels and assay substrates'
[patent_app_type] => 1
[patent_app_number] => 8/403649
[patent_app_country] => US
[patent_app_date] => 1995-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 7875
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650284.pdf
[firstpage_image] =>[orig_patent_app_number] => 403649
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/403649 | Enhancing the sensitivity of immunoassay procedures by use of antibodies directed to the product of a reaction between probe labels and assay substrates | Mar 13, 1995 | Issued |
08/395520 | PROCESSES FOR INSERTING DNA INTO EUCARYOTIC CELLS AND FOR PRODUCING PROTEINACEOUS MATERIALS | Feb 26, 1995 | Abandoned |
Array
(
[id] => 3759952
[patent_doc_number] => 05721353
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-24
[patent_title] => 'DNAs coding for ›LCU.sup.13 ! motilin'
[patent_app_type] => 1
[patent_app_number] => 8/387566
[patent_app_country] => US
[patent_app_date] => 1995-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 13880
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/721/05721353.pdf
[firstpage_image] =>[orig_patent_app_number] => 387566
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/387566 | DNAs coding for ›LCU.sup.13 ! motilin | Feb 12, 1995 | Issued |
Array
(
[id] => 3646817
[patent_doc_number] => 05605690
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-25
[patent_title] => 'Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor'
[patent_app_type] => 1
[patent_app_number] => 8/385229
[patent_app_country] => US
[patent_app_date] => 1995-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11018
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/605/05605690.pdf
[firstpage_image] =>[orig_patent_app_number] => 385229
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/385229 | Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor | Feb 7, 1995 | Issued |
Array
(
[id] => 3885061
[patent_doc_number] => 05714350
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region'
[patent_app_type] => 1
[patent_app_number] => 8/372262
[patent_app_country] => US
[patent_app_date] => 1995-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8510
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714350.pdf
[firstpage_image] =>[orig_patent_app_number] => 372262
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/372262 | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region | Jan 12, 1995 | Issued |
Array
(
[id] => 3683019
[patent_doc_number] => 05690935
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-25
[patent_title] => 'Biotherapy of cancer by targeting TP-3/P80'
[patent_app_type] => 1
[patent_app_number] => 8/372608
[patent_app_country] => US
[patent_app_date] => 1995-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 7375
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/690/05690935.pdf
[firstpage_image] =>[orig_patent_app_number] => 372608
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/372608 | Biotherapy of cancer by targeting TP-3/P80 | Jan 12, 1995 | Issued |
Array
(
[id] => 3507006
[patent_doc_number] => 05587161
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-24
[patent_title] => 'Prodrugs for antibody directed enzyme prodrug therapy'
[patent_app_type] => 1
[patent_app_number] => 8/361424
[patent_app_country] => US
[patent_app_date] => 1994-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22874
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1030
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/587/05587161.pdf
[firstpage_image] =>[orig_patent_app_number] => 361424
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/361424 | Prodrugs for antibody directed enzyme prodrug therapy | Dec 20, 1994 | Issued |
08/359263 | PEPTIDE FRAGMENTS AND ANALOGS OF THROMBOSPONDIN | Dec 18, 1994 | Abandoned |
Array
(
[id] => 3663071
[patent_doc_number] => 05599560
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Method of treating depression using neurotrophins'
[patent_app_type] => 1
[patent_app_number] => 8/337321
[patent_app_country] => US
[patent_app_date] => 1994-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4583
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599560.pdf
[firstpage_image] =>[orig_patent_app_number] => 337321
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/337321 | Method of treating depression using neurotrophins | Nov 9, 1994 | Issued |
Array
(
[id] => 3625748
[patent_doc_number] => 05686249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Test for determining frost hardiness of conifer seedlings and protein and antibody related thereto'
[patent_app_type] => 1
[patent_app_number] => 8/338127
[patent_app_country] => US
[patent_app_date] => 1994-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9102
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686249.pdf
[firstpage_image] =>[orig_patent_app_number] => 338127
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/338127 | Test for determining frost hardiness of conifer seedlings and protein and antibody related thereto | Nov 8, 1994 | Issued |
08/327423 | BIOLOGICALLY ACTIVE EPH FAMILY LIGANDS | Oct 20, 1994 | Abandoned |